Ultrafine Silica Powder: Particle Sizes, Specifications and Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Cabot Cab-O-Sil: Product Range, Key Grades and Alternatives
  • Keywords: silica sand
  • Published: 2026-11-20 01:35:54
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
In recent years, mesoporous silica nanocarriers have attracted great interest in pharmaceutical science because of their advantageous properties. Straightforward synthesis, low production cost, and tunable physicochemical properties characterize them. Their behavior in the human body, including targeting possibilities, can be influenced by particle size, particle morphology, pore size, internal structure, and surface chemistry. By modifying the surface functional groups and the surface charge, targeted therapy is achievable in several medical conditions. A wide range of drug loading methods is available (whether solvent-based or solvent-free techniques), so the most appropriate method can be selected, and higher drug concentration can be encapsulated, enhancing loading efficiency. Nevertheless, their formulation for different delivery routes, such as dermal, pulmonary, or the most favorable oral administration, is very difficult due to their large particular surface, adhesivity, and low density, which leads to poor powder flow properties, posing a huge difficulty in the manufacturing and formulation of solid dosage forms. Agglomeration of the particles by granulation or pelletization is a brilliant remedy for enhancing flowability. Concluding this, the granulation process of mesoporous silica has to be investigated and optimized to sustain the initially high porosity and high particular surface area of the material.

Glass Beads vs Silica Microspheres: Differences and Uses

Silica Tapped Density: Definition, Measurement and Typical Values
8. Conclusions
Silica Exposure Limits: OSHA, ACGIH and EU Limits Compared
17. Bavnhøj C.G., Knopp M.M., Madsen C.M., Löbmann K. The part interplay between mesoporous silica pore volume and surface area and their impact on drug loading ability. Int. J. Pharm. X. 2019;1:100008. doi: 10.1016/j.ijpx.2019.100008. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
Silica Aerogel Insulation: Thermal Performance, Uses and Cost Comparison
Silica for Rheology Control: How to Select the Right Silica and Dosage

Nouryon Levasil: Colloidal Silica Product Range and Applications

What is silica (SiO₂)?

fumed silica price

What is the difference between fumed silica and precipitated silica?

silica supplier Europe Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].

What drives silica raw material prices?

matting agent for coatings 6.2.1. Dermal Drug Administration

Cite this article: Silica Raw Materials News. "Silica vs Silicon: What Is the Difference? ." Published 2026-11-20 01:35:54. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.